Invesco Mortgage Capital (IVR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
20 Mar, 2026Executive summary
The 2026 proxy statement outlines board activities, governance, and performance highlights for the prior year, including a 13.2% economic return and a dividend increase in December 2025, attributed to strong agency mortgage performance and capital allocation initiatives.
The board issued 10 million shares of common stock and repurchased 353,000 shares of preferred stock in 2025, reducing preferred equity as a percentage of total capital from 24% to 21%.
Board composition was refreshed with the addition of two new directors in 2025 and 2026, and the retirement of long-serving members, enhancing diversity and expertise.
The board remains focused on risk management, transparency, and long-term value creation, with a constructive outlook for agency MBS markets.
Voting matters and shareholder proposals
Shareholders are asked to elect six directors, approve executive compensation on an advisory basis, and ratify the appointment of PricewaterhouseCoopers LLP as independent auditor for 2026.
The board recommends voting FOR all proposals.
Only holders of record as of March 12, 2026, are entitled to vote at the annual meeting on May 5, 2026.
Board of directors and corporate governance
The board consists of a majority of independent directors, with an independent chair and all committees composed exclusively of independent directors.
Board refreshment and diversity are emphasized, with policies ensuring women and underrepresented groups are included in candidate pools.
Annual board and committee evaluations are conducted with the help of an external advisor.
Directors are subject to stock ownership requirements and restrictions on insider trading and overboarding.
Latest events from Invesco Mortgage Capital
- Director elections, executive pay, and auditor ratification up for vote at the 2026 annual meeting.IVR
Proxy filing20 Mar 2026 - Book value per share rose 3.7% to $8.72, with an 8.0% economic return and higher dividend.IVR
Q4 20252 Feb 2026 - Book value per share fell 8% in Q2, but distributable earnings and dividend remained stable.IVR
Q2 20241 Feb 2026 - Q3 2024 saw a return to profitability, higher book value, and a 5.4% economic return.IVR
Q3 202416 Jan 2026 - Book value dropped 4.8% in Q4, with net loss and improved capital structure amid volatility.IVR
Q4 202423 Dec 2025 - Shelf registration allows up to $650M in securities for REIT investment and capital needs.IVR
Registration Filing16 Dec 2025 - Board seeks approval for director elections, executive pay, and auditor ratification amid strong governance.IVR
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification up for vote at May 2025 meeting.IVR
Proxy Filing1 Dec 2025 - Earnings rebounded in Q1 2025, but book value fell as volatility and risks persisted.IVR
Q1 202525 Nov 2025